Head and Shoulders pattern complete, we are 32% down from all time high. We have retraced to the 0.5 Fib level and bounced at the key $100 level. Trade entered with a tight stop loss, in case we lose that key $100 level.
The correction may be over in this top Pharma stock. Eli had terrible earnings but Novo looks more promising at this stage. Cagrisema phase 3 results due in the next 4 weeks.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.